Join us for a poster highlight of the top abstracts from the Liver Cancer SIG.&nbsp;<br />
&nbsp;

Join us for a poster highlight of the top abstracts from the Hepatitis B/Delta (HBV/HDV) SIG.&nbsp;<br />
&nbsp;

Join a panel of patients, caregivers, and patient advocacy leaders who participated in the National Liver Gathering, a first-of-its-kind scientific conference that places patients at the center of research, clinical practice, and policy discussions.<br />
<br />
This session will share key insights from across disease areas, including MASH, viral hepatitis elimination, harm reduction, rare liver diseases, liver cancer, transplantation, and pediatric liver disease &mdash; and reflect on how patient voices shaped the conversations.<br />
<br />
Attendees will learn how this model fosters collaboration between the scientific and patient communities and will have an opportunity to discuss how to expand this patient-centered approach nationally.<br />
<br />
<strong>Zoom:</strong> <a href="https://us02web.zoom.us/j/84067329881?pwd=jRzdmOz9cUQLP7tT4Y6Ce5HcpCRLd…;

Join the Friends of the PBC Foundation, NFP in a patient-led discussion on the unmet needs of the U.S. PBC patient community and how to better address them in 2026 and beyond.<br />
<br />
Zoom link for the PBC Community Conversation<strong>:</strong>&nbsp;<a href="http://https://us06web.zoom.us/j/82651012192?pwd=493L6C56dZGd1hTQBRMibb…;

Presenters in this symposium focus on the varied functions of liver endothelial cells (ECs). ECs are specialized cells increasingly recognized for their heterogeneity and their key role in liver diseases and carcinogenesis. Recent advances in the understanding of EC function were made possible with refined isolation techniques coupled with multiomics studies. Speakers review emerging literature that defines liver ECs beyond their role as vascular barriers to critical mediators in various biological processes under physiologic and pathologic conditions. 

Presenters in this symposium focus on the varied functions of liver endothelial cells (ECs). ECs are specialized cells increasingly recognized for their heterogeneity and their key role in liver diseases and carcinogenesis. Recent advances in the understanding of EC function were made possible with refined isolation techniques coupled with multiomics studies. Speakers review emerging literature that defines liver ECs beyond their role as vascular barriers to critical mediators in various biological processes under physiologic and pathologic conditions.

Join us as we discuss the importance of early identification of MASH (metabolic&nbsp;dysfunction-associated steatohepatitis), including how to accurately identify and select patients who are at risk for clinically significant fibrosis. We will also discuss clinical trial data for patients with MASH and stage 2 or 3 fibrosis.<br />
<br />
Industry Supporter:&nbsp;Novo Nordisk, Inc.

Join us for a poster highlight of the top abstracts from the Clinical Practice SIG.&nbsp;<br />
&nbsp;

The following poster categories will be in the Poster Hall:
<ul>
<li>MASLD/MASH - Experimental: Basic</li>
<li>Hepatitis B</li>
<li>Hepatitis C</li>
<li>MASLD/MASH - Experimental: Clinical</li>
<li>Alcohol-Associated Liver Diseases: Clinical and Experimental</li>
</ul>

Presenters explore new practice paradigms for optimizing liver tarnsplant acccess and examine effective strategies for dissemination of knowledge regarding the benefit of living donor liver transplant (LDLT) through directed, nondirected, and paired donation. Other topics include the role of machine perfusion in improving transplant access, outreach hepatology and transplant clinics, telehepatology, and the role of minimally-invasive surgical techniques in the growth of LDLT programs.